AGN-229666

DRUG3 trials

Sponsors

Allergan

Conditions

Allergic ConjunctivitisConjunctivitis, Allergic

Phase 2

AGN-229666 for the Treatment of Allergic Conjunctivitis

CompletedNCT01754766

AllerganAllergic Conjunctivitis

Start: 2012-10-31End: 2013-02-28Updated: 2014-02-04

Phase 3

AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

CompletedNCT02082262

AllerganConjunctivitis, Allergic

Start: 2014-03-31End: 2014-07-31Updated: 2016-03-14

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

CompletedNCT02161146

AllerganConjunctivitis, Allergic

Start: 2014-06-04End: 2014-12-20Updated: 2019-04-17